Proto Script Pharmaceutical Corp. (PSCR) Financial Metrics
This dashboard provides comprehensive financial metrics and analysis to help evaluate Proto Script Pharmaceutical Corp.'s investment potential. View key valuation ratios, profitability metrics, growth indicators, and historical trends to make informed investment decisions.
Financial Metrics Score
Valuation Metrics
Sector benchmarks: Industrials
P/E Ratio
-12.29
Earnings Deficit
P/B Ratio
-276.10
Equity Deficit
Earnings Yield
-8.14%
Yield Gap
Profitability Health
2016Return on Equity
2246.45%
Strong
WeakModerateStrong
Operating Margin
-37.78%
Weak
WeakModerateStrong
Net Profit Margin
-910.40%
Weak
WeakModerateStrong
Growth Indicators
2016Revenue Growth
-10.49%
Weak
WeakModerateStrong
Net Income Growth
-4845.11%
Weak
WeakModerateStrong
EPS Growth
-1493.75%
Weak
WeakModerateStrong
Efficiency & Liquidity
2016Current Ratio
0.30
Weak
WeakModerateStrong
Quick Ratio
0.30
Weak
WeakModerateStrong
Asset Turnover
4.64x
Strong
WeakModerateStrong
Inventory Turnover
-
No data
Cash Flow & Resilience
Core fortress metrics for cash-rich balance sheets in high-inflation / tech-volatility regimes
Free Cash Flow Yield
0.03%
Weak
WeakModerateStrong
EV / Free Cash Flow
3058.46x
Weak
WeakModerateStrong
Net Debt / EBITDA
-0.16x
Strong
WeakModerateStrong
Interest Burden (EBT / EBIT)
24.096
Strong
WeakModerateStrong
Return on Invested Capital
111.04%
Strong
WeakModerateStrong
Cash Conversion Cycle
-191.30 days
Strong
WeakModerateStrong
Fortress screener guardrails
3/4 passing
- FCF Yield > 3%
- Net Debt / EBITDA < 1.5x
- ROIC > 20%
- Cash Conversion Cycle < 0 days
Financial Statements
Want to see the complete financial picture? View detailed financial statements including income statements, balance sheets, and cash flow statements for PSCR.
View Financial Statements